GPX4 and cancer: Considering first the relevance of cysteine cellular intake and then of transsulfuration pathways in this process, their inhibition could represent another efficient strategy to stimulate ferroptosis in cancer cells, retracing the path of canonical ferroptosis inducers (i.e., erastin and RSL3) in blocking the XC−/GSH/GPX4 axis [201].